These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 28795340)

  • 1. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
    Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone density and turnover in Addison's disease: effect of glucocorticoid treatment.
    Valero MA; Leon M; Ruiz Valdepeñas MP; Larrodera L; Lopez MB; Papapietro K; Jara A; Hawkins F
    Bone Miner; 1994 Jul; 26(1):9-17. PubMed ID: 7950508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the optimal bone-preserving strategy for patients with Addison's disease?
    Lee P; Greenfield JR
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):157-61. PubMed ID: 25640730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density in patients with treated Addison's disease.
    Braatvedt GD; Joyce M; Evans M; Clearwater J; Reid IR
    Osteoporos Int; 1999; 10(6):435-40. PubMed ID: 10663342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease.
    Furman K; Gut P; Sowińska A; Ruchała M; Fichna M
    Endocrine; 2024 May; 84(2):711-719. PubMed ID: 38334892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of bone mineral density in Addison's disease.
    Jódar E; Valdepeñas MP; Martinez G; Jara A; Hawkins F
    Clin Endocrinol (Oxf); 2003 May; 58(5):617-20. PubMed ID: 12699444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
    Løvås K; Gjesdal CG; Christensen M; Wolff AB; Almås B; Svartberg J; Fougner KJ; Syversen U; Bollerslev J; Falch JA; Hunt PJ; Chatterjee VK; Husebye ES
    Eur J Endocrinol; 2009 Jun; 160(6):993-1002. PubMed ID: 19282465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual dysfunctions in men affected by autoimmune Addison's disease before and after short-term gluco- and mineralocorticoid replacement therapy.
    Granata A; Tirabassi G; Pugni V; Arnaldi G; Boscaro M; Carani C; Balercia G
    J Sex Med; 2013 Aug; 10(8):2036-43. PubMed ID: 22429298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density is reduced in female but not male subjects with Addison's disease.
    Florkowski CM; Holmes SJ; Elliot JR; Donald RA; Espiner EA
    N Z Med J; 1994 Feb; 107(972):52-3. PubMed ID: 8115069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement therapy in Addison's disease.
    Løvås K; Husebye ES
    Expert Opin Pharmacother; 2003 Dec; 4(12):2145-9. PubMed ID: 14640913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR; Ventz M; Diederich S; Quinkler M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Introduction: Patients with primary adrenal insufficiency receive long - term glucocorticoid replacement therapy, which may cause osteoporosis].
    Vaňuga P; Ságová I
    Vnitr Lek; 2021; 67(5):264-269. PubMed ID: 35459392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
    Rehman Q; Lang T; Modin G; Lane NE
    Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid.
    Chikada N; Imaki T; Hotta M; Sato K; Takano K
    Endocr J; 2004 Jun; 51(3):355-60. PubMed ID: 15256782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
    Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
    Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
    Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
    Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional calcium absorption is increased in girls with Rett syndrome.
    Motil KJ; Schultz RJ; Abrams S; Ellis KJ; Glaze DG
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):419-26. PubMed ID: 16641581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of corticosteroid replacement therapy and its effect on bones in Addison's disease].
    Heureux F; Maiter D; Boutsen Y; Devogelaer JP; Jamart J; Donckier J
    Ann Endocrinol (Paris); 2000 Sep; 61(3):179-83. PubMed ID: 10970940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
    Smans L; Lentjes E; Hermus A; Zelissen P
    Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.